Stocknear Logo Stocknear
/
Popular
Login

Matthew Weston

Stock Analyst at UBS

(0)
# 3718
Out of 5,288 analysts
3
Total ratings
0.00%
Success rate
-0.48%
Average return
Main Sectors:
Healthcare
Top Industries:
Drug Manufacturers - General
2 Stocks
Name Action Price Target Current % Upside Ratings Updated
Novartis
Downgrades: Neutral
n/a
n/a n/a 1 Feb 13, 2025
AstraZeneca
Upgrades: Buy
n/a
n/a n/a 2 Feb 13, 2025